Fund's Trasylol Marketing Suit Against Bayer Nixed
A federal judge has thrown out a proposed class action against Bayer Corp. over alleged fraud in the marketing of the lucrative blood-clotting drug Trasylol, though he has given the plaintiff,...To view the full article, register now.
Already a subscriber? Click here to view full article